High Quality Content by WIKIPEDIA articles! Sipuleucel-T (APC8015, Provenge), manufactured by Dendreon Corporation, is a therapeutic cancer vaccine for prostate cancer (CaP). It must be prepared specifically for each patient. In metastatic prostate cancer, it has extended survival by about four months. It costs $93,000 for a course of treatment.